Computational Strategies for Assessing Adverse Outcome Pathways: Hepatic Steatosis as a Case Study

Int J Mol Sci. 2024 Oct 17;25(20):11154. doi: 10.3390/ijms252011154.

Abstract

The evolving landscape of chemical risk assessment is increasingly focused on developing tiered, mechanistically driven approaches that avoid the use of animal experiments. In this context, adverse outcome pathways have gained importance for evaluating various types of chemical-induced toxicity. Using hepatic steatosis as a case study, this review explores the use of diverse computational techniques, such as structure-activity relationship models, quantitative structure-activity relationship models, read-across methods, omics data analysis, and structure-based approaches to fill data gaps within adverse outcome pathway networks. Emphasizing the regulatory acceptance of each technique, we examine how these methodologies can be integrated to provide a comprehensive understanding of chemical toxicity. This review highlights the transformative impact of in silico techniques in toxicology, proposing guidelines for their application in evidence gathering for developing and filling data gaps in adverse outcome pathway networks. These guidelines can be applied to other cases, advancing the field of toxicological risk assessment.

Keywords: adverse outcome pathway; computational toxicity; hepatic steatosis; molecular mechanisms; new generation risk assessment.

Publication types

  • Review

MeSH terms

  • Adverse Outcome Pathways*
  • Animals
  • Computational Biology / methods
  • Computer Simulation
  • Fatty Liver* / metabolism
  • Humans
  • Quantitative Structure-Activity Relationship
  • Risk Assessment / methods